Cargando…

Pharma partnering: other people’s science

Partnering is an ideal field if someone is seeking to move from a scientific to a more business-oriented discipline. Partnering’s goal is to identify and acquire external innovation. These discoveries are then included in a company’s pipeline and help bring novel treatments to patients. Advanced sci...

Descripción completa

Detalles Bibliográficos
Autor principal: Hofmann, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society for Cell Biology 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5221633/
https://www.ncbi.nlm.nih.gov/pubmed/28035041
http://dx.doi.org/10.1091/mbc.E16-07-0512
_version_ 1782492855261986816
author Hofmann, Christian
author_facet Hofmann, Christian
author_sort Hofmann, Christian
collection PubMed
description Partnering is an ideal field if someone is seeking to move from a scientific to a more business-oriented discipline. Partnering’s goal is to identify and acquire external innovation. These discoveries are then included in a company’s pipeline and help bring novel treatments to patients. Advanced scientific training is essential in the identification and evaluation of these external assets. Here I describe how partnering works in a pharmaceutical company and offer advice on how to make a successful transition from a PhD program to a business career.
format Online
Article
Text
id pubmed-5221633
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher The American Society for Cell Biology
record_format MEDLINE/PubMed
spelling pubmed-52216332017-03-16 Pharma partnering: other people’s science Hofmann, Christian Mol Biol Cell Perspectives Partnering is an ideal field if someone is seeking to move from a scientific to a more business-oriented discipline. Partnering’s goal is to identify and acquire external innovation. These discoveries are then included in a company’s pipeline and help bring novel treatments to patients. Advanced scientific training is essential in the identification and evaluation of these external assets. Here I describe how partnering works in a pharmaceutical company and offer advice on how to make a successful transition from a PhD program to a business career. The American Society for Cell Biology 2017-01-01 /pmc/articles/PMC5221633/ /pubmed/28035041 http://dx.doi.org/10.1091/mbc.E16-07-0512 Text en © 2017 Hofmann. This article is distributed by The American Society for Cell Biology under license from the author(s). Two months after publication it is available to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0). “ASCB®,” “The American Society for Cell Biology®,” and “Molecular Biology of the Cell®” are registered trademarks of The American Society for Cell Biology.
spellingShingle Perspectives
Hofmann, Christian
Pharma partnering: other people’s science
title Pharma partnering: other people’s science
title_full Pharma partnering: other people’s science
title_fullStr Pharma partnering: other people’s science
title_full_unstemmed Pharma partnering: other people’s science
title_short Pharma partnering: other people’s science
title_sort pharma partnering: other people’s science
topic Perspectives
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5221633/
https://www.ncbi.nlm.nih.gov/pubmed/28035041
http://dx.doi.org/10.1091/mbc.E16-07-0512
work_keys_str_mv AT hofmannchristian pharmapartneringotherpeoplesscience